| 2025 | 2024 | 2023 | ||||
|---|---|---|---|---|---|---|
| Gross margin | -33,2 k € | +4.7% | -34,9 k € | -647.6% | -4,7 k € | |
| EBITDA | -33,9 k € | +3.6% | -35,1 k € | -637.0% | -4,8 k € | |
| Operating profit | -33,9 k € | +3.6% | -35,1 k € | -637.0% | -4,8 k € | |
| Profit/loss | -31,5 k € | +10.4% | -35,1 k € | -631.8% | -4,8 k € | |
| Equity | 228,5 k € | -12.1% | 260,1 k € | -11.9% | 295,2 k € | |
| Total assets | 230,0 k € | -13.8% | 266,7 k € | -9.7% | 295,2 k € | |
| Cash | 3,3 k € | -98.8% | 266,7 k € | -9.7% | 295,2 k € | |
| Debts | 1,5 k € | -78.1% | 6,6 k € | — | ||
Source: Belgian Official Gazette
Private limited company · Evergem · incorporated on 17/05/2022
Private limited company loss-making in the latest fiscal year. Cash position declining (-98.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
MENTANA DX is a Private limited company incorporated in 2022. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Evergem.